Tag Archives: PJT

Top 5 Undervalued Stocks To Own For 2019

Willamette Valley Vineyards (NASDAQ: WVVI) is a nano-cap winery located in Turner, Oregon. The company produces various mid end, premium, and ultra-premium wines including the Pinot Noir, Chardonnay, Pinot Gris, Ros茅 and Riesling varieties. We usually cover tech stocks but we are big fans of wine and even bigger fans of undervalued stocks; WVVI certainly fits the bill for both. WVVI has enjoyed tremendous average sales and EBITDA growth of 12.8% and 16% respectively for the past 3 years. During the same time period, investors have been met with a modest stock growth of 23.75% from $6.10 to $8 currently. With a market cap of only $40 million and a fair P/E of 22, we believe there is still undiscovered potential for this profitable company and its drought-free wine business.

The Economy of Wine

In the past 6 years, United States wine consumption has seen healthy growth from 336.3 million 9 liter cases in 2010 to 383.9 million 9 liter cases in 2015, This resulted in the total retail value of wine increasing from $46.5 billion in 2010 to $55.8 billion in 2015, a significant 20% growth rate. According to a recent report by goodfruits.com, this growth trend continued in 2016 as “September U.S. wine sales rose from $3.3 billion to $3.7 billion, helping set an annual pace to boost the industry’s overall retail value for the 11th consecutive year”. The prior three 5 year periods has seen total retail value increase by 8.8 billion (2001-2005), 5 billion (2006-2010) and 7.2 (2011-2015). We expect the wine market retail value to grow 1.5% (average growth of the last 3 years) in 2017 and surpass $62 billion by 2020. This growth in wine consumption is further fueled by the inauguration of Donald Trump, whose victory has left many oppositions drinking to a stupor. Under these conditions, we believe specialize vineyards like WVVI are going to earn steady and growing profits for years to come.

Top 5 Undervalued Stocks To Own For 2019: Foamix Pharmaceuticals Ltd.(FOMX)

Advisors’ Opinion:

  • [By Stephan Byrd]

    Press coverage about Foamix Pharmaceuticals (NASDAQ:FOMX) has trended somewhat positive this week, according to Accern Sentiment. Accern identifies positive and negative media coverage by reviewing more than 20 million news and blog sources in real time. Accern ranks coverage of publicly-traded companies on a scale of negative one to one, with scores closest to one being the most favorable. Foamix Pharmaceuticals earned a news impact score of 0.14 on Accern’s scale. Accern also assigned press coverage about the specialty pharmaceutical company an impact score of 45.4298608245084 out of 100, indicating that recent media coverage is somewhat unlikely to have an impact on the stock’s share price in the near term.

Top 5 Undervalued Stocks To Own For 2019: PJT Partners Inc.(PJT)

Advisors’ Opinion:

  • [By Joseph Griffin]

    Get a free copy of the Zacks research report on PJT Partners (PJT)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

Top 5 Undervalued Stocks To Own For 2019: NovoCure Limited(NVCR)

Advisors’ Opinion:

  • [By Stephan Byrd]

    Get a free copy of the Zacks research report on Novocure (NVCR)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Brian Feroldi]

    After the company announced details of its phase 3 INNOVATE-3 trial at theAmerican Society of Clinical Oncology (ASCO) annual meeting, shares ofNovoCure (NASDAQ:NVCR), a red-hot medical device companyfocused on cancer, fell as much as12% in early morning trading today. Shares were down about 10% as of 10:30 a.m. EDT.

  • [By Ethan Ryder]

    NovoCure (NASDAQ:NVCR) Director Gabriel Leung sold 80,000 shares of the firm’s stock in a transaction on Wednesday, May 16th. The stock was sold at an average price of $28.83, for a total value of $2,306,400.00. The sale was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this link.

  • [By Chris Lange]

    Novocure Ltd. (NASDAQ: NVCR) announced results from its Phase 3 INNOVATE trial of TTFields in platinum-resistant ovarian cancer. There were no major surprises, except study size is larger than some investors expected, which is not concerning. INNOVATE-3 is set to start later this year and as previously announced will enroll patients with recurrent platinum-resistant ovarian cancer.

  • [By Max Byerly]

    Get a free copy of the Zacks research report on NovoCure (NVCR)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

Top 5 Undervalued Stocks To Own For 2019: Nektar Therapeutics(NKTR)

Advisors’ Opinion:

  • [By Todd Campbell]

    Surprising and market-moving information often comes out of the annual American Society of Clinical Oncologists (ASCO) meeting, and so far, ASCO18 hasn’t disappointed. From bluebird bio’s (NASDAQ:BLUE) great-but-not-good-enough results in multiple myeloma to Loxo Oncology’s (NASDAQ:LOXO) stellar results in RET-fusion cancers to Nektar Therapeutics (NASDAQ:NKTR) head-scratching data,here are some quick takes on the data released this weekend.

  • [By Stephan Byrd]

    TRADEMARK VIOLATION NOTICE: “Nektar Therapeutics (NKTR) Trading Down 7%” was originally reported by Ticker Report and is the property of of Ticker Report. If you are reading this piece of content on another site, it was stolen and republished in violation of US & international trademark and copyright law. The original version of this piece of content can be viewed at www.tickerreport.com/banking-finance/3362849/nektar-therapeutics-nktr-trading-down-7.html.

  • [By Ethan Ryder]

    Nektar Therapeutics (NASDAQ:NKTR) has been given a consensus recommendation of “Buy” by the fifteen ratings firms that are presently covering the stock, MarketBeat.com reports. Three research analysts have rated the stock with a hold rating, eleven have given a buy rating and one has assigned a strong buy rating to the company. The average 12 month price target among brokers that have issued a report on the stock in the last year is $85.09.

Top 5 Undervalued Stocks To Own For 2019: LightPath Technologies, Inc.(LPTH)

Advisors’ Opinion:

  • [By Lisa Levin] Gainers
    Euro Tech Holdings Company Limited (NASDAQ: CLWT) shares rose 14.1 percent to $3.65 in the pre-market trading session after reporting 2017 year-end results.
    LightPath Technologies, Inc. (NASDAQ: LPTH) rose 13.3 percent to $2.43 in pre-market trading after reporting a third-quarter earnings beat.
    MYnd Analytics, Inc. (NASDAQ: MYND) rose 10.5 percent to $3.49 in pre-market trading. MYnd Analytics reported a Q2 net loss of $2.7 million on revenue of $459,900.
    SORL Auto Parts, Inc. (NASDAQ: SORL) shares rose 8.4 percent to $5.68 in pre-market trading after reporting upbeat Q1 results.
    Famous Dave's of America, Inc. (NASDAQ: DAVE) shares rose 7.7 percent to $8.40 in pre-market trading after the company reported upbeat earnings for its first quarter on Monday.
    Xenon Pharmaceuticals Inc. (NASDAQ: XENE) rose 7.5 percent to $6.45 in pre-market trading after the company presented XEN901 Phase 1 clinical update and XEN1101 TMS pharmacodynamic Phase 1 data.
    Mimecast Ltd (NASDAQ: MIME) rose 6.5 percent to $43.50 in pre-market trading following a first-quarter sales beat.
    Boxlight Corporation (NASDAQ: BOXL) rose 6 percent to $12.50 in pre-market trading after surging 77.44 percent on Monday.
    Intellia Therapeutics, Inc. (NASDAQ: NTLA) shares rose 6 percent to $26.05 in pre-market trading after climbing 3.58 percent on Monday.
    PPDAI Group Inc. (NASDAQ: PPDF) rose 4.7 percent to $7.20 in pre-market trading following Q1 results.
    Xunlei Limited (NASDAQ: XNET) rose 4.1 percent to $13.88 in pre-market trading after gaining 2.54 percent on Monday.
    Valeant Pharmaceuticals International, Inc. (NYSE: VRX) shares rose 4.5 percent to $21.73 in pre-market trading. Mizuho upgraded Valeant from Neutral to Buy.
    Bovie Medical Corporation (NYSE: BVX) rose 4.1 percent to $3.80 in pre-market trading after reporting a first-quarter sales beat.
    Myomo, Inc. (NYSE: MYO) rose 3.4 percent to $4.00 in pre-market trading after jumping 23.25 percent o
  • [By Joseph Griffin]

    Headlines about LightPath Technologies (NASDAQ:LPTH) have been trending somewhat positive on Monday, Accern Sentiment reports. The research group identifies positive and negative press coverage by monitoring more than twenty million news and blog sources in real-time. Accern ranks coverage of public companies on a scale of negative one to positive one, with scores closest to one being the most favorable. LightPath Technologies earned a daily sentiment score of 0.14 on Accern’s scale. Accern also assigned press coverage about the technology company an impact score of 46.9867601112654 out of 100, indicating that recent press coverage is somewhat unlikely to have an impact on the company’s share price in the next several days.

Top 10 Stocks To Own Right Now

First Internet Bancorp (NASDAQ:INBK) was downgraded by equities research analysts at ValuEngine from a “buy” rating to a “hold” rating in a report issued on Wednesday.

Several other brokerages have also issued reports on INBK. BidaskClub raised shares of First Internet Bancorp from a “hold” rating to a “buy” rating in a report on Saturday, March 3rd. Zacks Investment Research raised shares of First Internet Bancorp from a “strong sell” rating to a “hold” rating in a report on Tuesday, March 27th. Keefe, Bruyette & Woods reissued a “buy” rating on shares of First Internet Bancorp in a report on Friday, April 20th. Craig Hallum began coverage on shares of First Internet Bancorp in a report on Monday, May 21st. They issued a “buy” rating and a $50.00 price target for the company. Finally, Sandler O’Neill reaffirmed a “buy” rating and issued a $43.00 target price on shares of First Internet Bancorp in a research note on Friday, April 20th. Two analysts have rated the stock with a sell rating, two have issued a hold rating and five have given a buy rating to the company. The stock has an average rating of “Hold” and a consensus price target of $45.00.

Top 10 Stocks To Own Right Now: Blackstone GSO Senior Floating Rate Term Fund(BSL)

Advisors’ Opinion:

  • [By Stephan Byrd]

    News articles about Blackstone/GSO Senior Fltg Rt Term Fund (NYSE:BSL) have trended somewhat positive this week, Accern Sentiment reports. Accern identifies negative and positive news coverage by monitoring more than twenty million blog and news sources in real-time. Accern ranks coverage of public companies on a scale of -1 to 1, with scores closest to one being the most favorable. Blackstone/GSO Senior Fltg Rt Term Fund earned a daily sentiment score of 0.19 on Accern’s scale. Accern also gave news coverage about the company an impact score of 47.9711105753708 out of 100, indicating that recent news coverage is somewhat unlikely to have an effect on the stock’s share price in the near term.

Top 10 Stocks To Own Right Now: Atkore International Group Inc. (ATKR)

Advisors’ Opinion:

  • [By Stephan Byrd]

    Atkore International Group (NYSE:ATKR) was the target of some unusual options trading activity on Monday. Investors acquired 2,000 put options on the company. This is an increase of approximately 1,842% compared to the average daily volume of 103 put options.

  • [By Max Byerly]

    Atkore International Group (NYSE:ATKR) insider John Patrick Williamson sold 5,151 shares of the stock in a transaction on Thursday, May 17th. The shares were sold at an average price of $21.00, for a total value of $108,171.00. The sale was disclosed in a document filed with the SEC, which is available at this hyperlink.

  • [By Joseph Griffin]

    Atkore International Group Inc (NYSE:ATKR) has been given an average rating of “Buy” by the seven research firms that are presently covering the stock, MarketBeat Ratings reports. Three analysts have rated the stock with a hold recommendation and three have given a buy recommendation to the company. The average twelve-month target price among analysts that have updated their coverage on the stock in the last year is $23.75.

Top 10 Stocks To Own Right Now: Genomic Health, Inc.(GHDX)

Advisors’ Opinion:

  • [By Logan Wallace]

    Carillon Tower Advisers Inc. bought a new position in shares of Genomic Health (NASDAQ:GHDX) in the 1st quarter, according to the company in its most recent 13F filing with the SEC. The firm bought 75,375 shares of the medical research company’s stock, valued at approximately $2,358,000.

  • [By Shane Hupp]

    Genomic Health (NASDAQ: GHDX) and CareDx (NASDAQ:CDNA) are both small-cap medical companies, but which is the superior stock? We will compare the two companies based on the strength of their dividends, analyst recommendations, risk, profitability, institutional ownership, valuation and earnings.

  • [By Brian Orelli]

    Shares of Genomic Health (NASDAQ:GHDX) are up 18.6% at 1:23 p.m. EDT after data from the Trial Assigning Individualized Options for Treatment (TAILORx) trial was presented at the American Society of Clinical Oncology meeting and published in The New England Journal of Medicine.

  • [By Stephan Byrd]

    ELEKTA AB/ADR (OTCMKTS: EKTAY) and Genomic Health (NASDAQ:GHDX) are both medical companies, but which is the superior business? We will contrast the two companies based on the strength of their analyst recommendations, valuation, risk, institutional ownership, dividends, profitability and earnings.

  • [By Brian Orelli]

    Cancer-test maker Genomic Health (NASDAQ:GHDX) started the year on a high note, posting double-digit revenue growth, and would have turned a profit if not for an $8.5 millionone-time charge for stopping development of the Oncotype SEQ Liquid Select test, which was announced on the last quarterly call.

  • [By Logan Wallace]

    Genomic Health, Inc. (NASDAQ:GHDX) shares saw unusually-strong trading volume on Wednesday . Approximately 882,863 shares were traded during mid-day trading, an increase of 311% from the previous session’s volume of 214,696 shares.The stock last traded at $51.88 and had previously closed at $51.88.

Top 10 Stocks To Own Right Now: Orezone Gold Corp (ORE)

Advisors’ Opinion:

  • [By Stephan Byrd]

    Galactrum (ORE) is a PoW/PoS coin that uses the
    Lyra2RE hashing algorithm. It launched on November 11th, 2017. Galactrum’s total supply is 2,092,679 coins and its circulating supply is 1,372,679 coins. Galactrum’s official Twitter account is @galactrum. Galactrum’s official website is galactrum.org.

  • [By Jim Robertson]

    Finally, Richard Seville, the CEO of Brisbane-based Orocobre Ltd (ASX: ORE) which began lithium sales in 2015 from northern Argentina and also experienced difficulty boosting output, commented that an inability to access traditional funds has delayed the development of the sector and that these projects arent easy — so the banks just dont want to go there.

Top 10 Stocks To Own Right Now: Freshpet, Inc.(FRPT)

Advisors’ Opinion:

  • [By Ethan Ryder]

    Freshpet Inc (NASDAQ:FRPT) reached a new 52-week high and low during trading on Tuesday . The company traded as low as $22.75 and last traded at $22.65, with a volume of 5950 shares trading hands. The stock had previously closed at $22.35.

  • [By Max Byerly]

    Shares of Freshpet Inc (NASDAQ:FRPT) have been assigned a consensus rating of “Buy” from the eleven research firms that are presently covering the firm, Marketbeat Ratings reports. Five analysts have rated the stock with a hold recommendation, three have issued a buy recommendation and two have given a strong buy recommendation to the company. The average 12 month price objective among brokerages that have covered the stock in the last year is $20.60.

  • [By Peter Graham]

    A long term performance chart shows shares of Petmed Express and pet stock peerCentral Garden & Pet Co (NASDAQ: CENT) being outstanding performers over the last year or two while pet food stocks Blue Buffalo Pet Products Inc (NASDAQ: BUFF) and Freshpet Inc (NASDAQ: FRPT) have not yet lived up to investor expectations:

  • [By Lisa Levin]

    On Friday, the consumer staples shares surged 0.62 percent. Meanwhile, top gainers in the sector included Universal Corporation (NYSE: UVV), up 5 percent, and Freshpet, Inc. (NASDAQ: FRPT) up 4 percent.

Top 10 Stocks To Own Right Now: Citigroup Inc.(C)

Advisors’ Opinion:

  • [By Chris Lange]

    The Citigroup Inc. (NYSE: C) fourth-quarter report is scheduled for Friday. The consensus forecast is $1.61 in EPS on $18.8 billion in revenue. Shares closed at $68.60 apiece. The consensus price target is $83.41, and the 52-week range is $56.55 to $80.70.

  • [By ]

    As Deutsche Bank AG (DB) , Germany’s largest lender, retreats from its global ambitions in investment-banking and trading, Wall Street heavyweights JPMorgan Chase & Co. (JPM) , Citigroup Inc. (C) and Bank of America Corp. (BAC) are poised to pick up the business that’s left behind.

  • [By John Maxfield]

    Maxfield: I think we mixed up some numbers. Theirrevenue as a percent of assets is4.92%, which is the highest in its peer group, and itspeer group are the really large, too-big-to-fail banks,JPMorgan Chase(NYSE: JPM), Citigroup(NYSE: C), Bank of America(NYSE: BAC), Wells Fargo(NYSE: WFC), plusother large regional banks. So that’s the largestwith one exception, and that isCapital One(NYSE: COF). The reason that Capital One’srevenue is so high as a percentage of assets is because a very largeportion of its loan portfolioconsists of credit card loans, and those yield,as everybody knows, a lot more than, say, a homemortgage does. So its revenue as a percent of assets isthe top in its peer group. But then,if you translate that over intoprofitability,that’s where that 1.1% return on assets is. When you’retalking about profitability for banks, there’stwo measures that you want to look at: yourreturn on assets andyour return on equity. Return on assets is basically yourunlevered profitability. Your return on equity is your leveredprofitability. Here’s the interesting thing about PNC, andthis is one of the reasons that it doesn’t pop up a lot wheninvestors are looking for the top-performing banks — it’s because theirreturn on common equity last year was8.58%. When you’relooking for a 10% return on equity, you think, that’sactually meaningfully below that standard industry benchmark that you want to see. But the reason that it’s below,as we see with its good return on assets,is just because it’s not very levered,which means it’s a very safe bank that’sstill earning a lot of money if you look at it on a levered basis.

  • [By Garrett Baldwin]

    The Dow Jones today gained over 100 points in pre-market hours after the U.S. Federal Reserve announced the result of financial liquidity tests. The tests, performed on the nation’s largest financial institutions, are designed to provide feedback on the dividend and stock buyback plans proposed by firms like JPMorgan Chase & Co. (NYSE: JPM) and Citigroup Inc. (NYSE: C).

  • [By ]

    The political group is organized under section 501(c)(4) of the tax code, freeing it to run paid advertising, lobby policy makers and conduct aggressive social and digital campaigns with the aim of building support for the carbon tax plan. The group does not plan to be active in this November’s elections but organizers envision doing so in 2020.

Top 10 Stocks To Own Right Now: Rite Aid Corporation(RAD)

Advisors’ Opinion:

  • [By Max Byerly]

    These are some of the media headlines that may have effected Accern Sentiment’s scoring:

    Get Rite Aid alerts:

    Can Rite Aid Stock Bounce Back After Last Week’s 14% Drop? (fool.com) Can Rite Aid Stock Bounce Back After Last Week's 14% Drop? (finance.yahoo.com) Rite Aid Co. (RAD) Given Consensus Recommendation of “Hold” by Analysts (americanbankingnews.com) Rite Aid Co. (RAD) Expected to Announce Quarterly Sales of $5.35 Billion (americanbankingnews.com) Overnight Markets: Tech, financial stocks lift Wall Street (citywire.co.uk)

    NYSE RAD traded up $0.02 on Wednesday, hitting $1.70. 5,429,808 shares of the stock were exchanged, compared to its average volume of 20,022,604. Rite Aid has a 52-week low of $1.38 and a 52-week high of $2.80. The company has a debt-to-equity ratio of 1.75, a quick ratio of 0.85 and a current ratio of 1.49. The stock has a market cap of $1.79 billion, a price-to-earnings ratio of -85.00 and a beta of 1.69.

  • [By Keith Speights]

    Shares of major pharmacy chains CVS Health Corp. (NYSE:CVS), Rite Aid Corporation (NYSE:RAD), and Walgreens Boots Alliance Inc. (NASDAQ:WBA) sank by 9% or more as of 11:07 a.m. EDT on Thursday. All three stocks were impacted by the same big news:Amazon’s (NASDAQ:AMZN) acquisition of PillPack.

  • [By Money Morning News Team]

    Rite Aid Corp. (NYSE: RAD) is a national drugstore chain known for providing both over-the-counter medicine and prescription pharmaceuticals.

    Shares of the company have dropped over 60% in the last year due to bearish sentiment about the company’s odds of holding on to its market share in the face of increasing competition from CVS Health Corp. (NYSE: CVS) and Wal-Mart Stores Inc. (NYSE: WMT).

  • [By Garrett Baldwin]

    The secret to becoming a millionaire, of course, is getting out in front of a major investment trend before it becomes mainstream. In 2017, it was Bitcoin and cryptocurrencies. But this year, it’s a taboo investment that is creating millionaires all across North America. Tap into the “green rush,” and prepare to become a “Marijuana millionaire.” Learn how to get started right here.

    The Top Stock Market Stories for Wednesday
    U.S. President Donald Trump is facing criticism after threatening to ramp up taxes on Harley-Davidson Inc. (NYSE: HOG). The iconic motorcycle producer said it will move parts of its production overseas in order to avoid tariffs from the European Union. Trump threatened to increase taxes on the firm. “Surprised that Harley-Davidson, of all companies, would be the first to wave the White Flag,” Trump tweeted Tuesday. “I fought hard for them and ultimately they will not pay tariffs selling into the E.U., which has hurt us badly on trade, down $151 Billion. Taxes just a Harley excuse – be patient!” Earlier this month,Microsoft Corp.(Nasdaq:MSFT) launched a $7.5 billion takeover of the web-based hosting service GitHub. The acquisition, orchestrated by Microsoft CEO Satya Nadella, brought out critics who claim that GitHub lacks any real profit potential forMicrosoft stock. Here’s why those critics are wrong… and why MSFT is a buy. Facebook Inc. (Nasdaq: FB) has reversed its policy on cryptocurrency ads. The social media giant says that it will permit marketing from “pre-approved advisers.” According to TechCrunch, the company will still ban ads pushing binary options and initial coin offerings. The report goes on to explain that cryptocurrency scams cost customers more than $500 million in just January and February 2018 alone.
    Four Stocks to Watch Today: ORCL, FB, GOOGL, BA
    Oracle Corp. (NYSE: ORCL) were largely flat despite a strong earnings report after the bell yesterday. The cloud computing giant reported EPS of $0.99

  • [By Chris Lange]

    Rite Aid Corp. (NYSE: RAD) fiscal third-quarter report is scheduled for late on Wednesday. Consensus estimates are calling for a net loss of $0.02 per share and $7.45 billion in revenue. The shares closed trading at $1.97 apiece on Friday. The consensus price target is $2.11, and the 52-week trading range is $1.38 to $8.77.

  • [By Chris Lange]

    Rite Aid Corp. (NYSE: RAD) also is set to release its most recent quarterly results on Thursday. The consensus forecast calls for a net loss of $0.01 per share and $5.57 billion in revenue. Shares traded on Fridays close at $1.61. The consensus price target is $2.08, and the 52-week range is $1.38 to $4.87.

Top 10 Stocks To Own Right Now: EZCORP, Inc.(EZPW)

Advisors’ Opinion:

  • [By Stephan Byrd]

    EZCORP (NASDAQ: EZPW) and Zagg (NASDAQ:ZAGG) are both small-cap finance companies, but which is the superior stock? We will contrast the two businesses based on the strength of their analyst recommendations, profitability, institutional ownership, risk, dividends, valuation and earnings.

  • [By Max Byerly]

    JPMorgan Chase & Co. decreased its position in shares of EZCORP Inc (NASDAQ:EZPW) by 25.4% during the 1st quarter, according to its most recent filing with the Securities and Exchange Commission. The institutional investor owned 1,230,426 shares of the credit services provider’s stock after selling 417,887 shares during the period. JPMorgan Chase & Co. owned about 2.26% of EZCORP worth $16,241,000 as of its most recent filing with the Securities and Exchange Commission.

  • [By Joseph Griffin]

    News headlines about EZCORP (NASDAQ:EZPW) have trended somewhat positive on Tuesday, according to Accern Sentiment Analysis. Accern identifies positive and negative media coverage by reviewing more than twenty million blog and news sources in real-time. Accern ranks coverage of publicly-traded companies on a scale of -1 to 1, with scores closest to one being the most favorable. EZCORP earned a news impact score of 0.05 on Accern’s scale. Accern also gave press coverage about the credit services provider an impact score of 45.6717362487943 out of 100, indicating that recent media coverage is somewhat unlikely to have an impact on the stock’s share price in the next several days.

  • [By Ethan Ryder]

    SG Americas Securities LLC increased its position in EZCorp. (NASDAQ:EZPW) by 12.0% during the 1st quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 258,988 shares of the credit services provider’s stock after purchasing an additional 27,770 shares during the quarter. SG Americas Securities LLC owned approximately 0.48% of EZCorp. worth $3,419,000 as of its most recent SEC filing.

Top 10 Stocks To Own Right Now: CareDx, Inc.(CDNA)

Advisors’ Opinion:

  • [By Brian Orelli]

    Shares of CareDx (NASDAQ:CDNA) are down 21% at 2:26 p.m. EDT, ending a monthlong run rather abruptly in what appears to be a sell-the-news event.

  • [By Money Morning Staff Reports]

    After looking at this week’s penny stock gainers, we’ll give you that leg up with one of our top-rated penny stocks from our proprietary stock ranking system…

    Penny Stock Current Share Price (March 26) Last Week’s Gain
    Cartesian Inc. (OTCMKTS: CRTN) $0.39 170.69%
    Odyssey Marine Exploration Inc. (Nasdaq: OMEX) $8.76 135.90%
    iFresh Inc. (Nasdaq: IFMK) $8.25 64.64%
    China Auto Logistics Inc. (Nasdaq: CALI) $4.68 47.43%
    National American University Holdings Inc. (Nasdaq: NAUH) $1.20 39.29%
    Document Security Systems Inc. (NYSE: DSS) $1.58 33.91%
    Blonder Tongue Labs Inc. (NYSE: BDR) $0.77 33.90%
    CareDx Inc. (Nasdaq: CDNA) $7.49 29.88%
    Mediwound Ltd. (Nasdaq: MDWD) $5.10 26.51%
    New York & Co. Inc. (NYSE: NWY) $3.37 26.35%

    Don’t Miss This Shot at a $78,000 Windfall: This tiny firm is about to make the entire world wire-free. As its game-changing technology revolutionizes the global power structure, its stock could hand investors a massive return. Learn more…

  • [By Shane Hupp]

    Genomic Health (NASDAQ: GHDX) and CareDx (NASDAQ:CDNA) are both small-cap medical companies, but which is the superior stock? We will compare the two companies based on the strength of their dividends, analyst recommendations, risk, profitability, institutional ownership, valuation and earnings.

Top 10 Stocks To Own Right Now: PJT Partners Inc.(PJT)

Advisors’ Opinion:

  • [By Joseph Griffin]

    Get a free copy of the Zacks research report on PJT Partners (PJT)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com